Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer 2025; 14(02): 208-210
DOI: 10.1055/s-0044-1790221
Viewpoint
Quality of Life Section

Challenges in Targeting the “Crosstalks” in Cancer Cachexia

Authors

  • Dilip Harindran Vallathol

    1   Department of Medical Oncology, Aster Medcity, Cochin, Kerala, India
  • Arun R. Warrier

    1   Department of Medical Oncology, Aster Medcity, Cochin, Kerala, India

Abstract

Cancer cachexia syndrome is characterized by involuntary weight loss which usually occurs in advanced malignancies. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors. The syndrome is closely related to the prognostication of malignancies. Several research works are in progress to target the major effectors of cancer cachexia syndrome. This letter is a nutshell on the current status of the cancer cachexia syndrome—the crosstalks and potential therapeutic targets.



Publication History

Received: 30 July 2024

Accepted: 03 August 2024

Article published online:
02 September 2024

© 2024. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India